https://www.selleckchem.com/products/ipi-549.html
At 1-year follow-up, maximum total aorta diameter was decreased in the acute/subacute and early chronic groups and increased in the late chronic group (-4.3±9.3 vs. -5.2±6.9 vs. 2.5±4.6 mm, p less then .001). Survival free from major adverse aortic event (death, aortic rupture, or reintervention) at 5 years post-TEVAR was lowest in the late chronic group (92.6% vs. 88.2% vs. 73.1%, p=.033) but not significantly different between the acute/subacute and early chronic groups (p=.68. CONCLUSIONS TEVAR in the acute/subacute and early chron
Like
Comment
Share
